The last step in the biosynthesis of fosfomycin, an antibiotic used to treat diabetic foot infections and lower urinary tract infections, is catalysed by the non-haem-iron-dependent enzyme (S)-2-hydroxypropylphosphonate ((S)-2-HPP) epoxidase (HppE). The reaction involves an unusual dehydrogenation reaction in which the secondary alcohol of (S)-2-HPP is converted to the epoxide ring of fosfomycin. In this manuscript, the authors show that the enzyme can also catalyse a 1,2-phosphono-migration reaction, which is a biologically unprecedented chemical transformation. This finding could pave the way for the production of novel phosphonate-containing natural products and new phosphonate derivatives.
- Positive and radical (News & Views p34, doi: 10.1038/496034a)
- Mechanistic studies of an unprecedented enzyme-catalysed 1,2-phosphono-migration reaction (Letter p114, doi: 10.1038/nature11998)
Recent Hot Topics
Sign up for Nature Research e-alerts to get the lastest research in your inbox every week.